Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
AntibioticsORALGeneric

V-CILLIN K

PENICILLIN V POTASSIUM

Standard Dose
EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview V-CILLIN K is listed in Drugs@FDA under application 060003 (ANDA).

Marketing status: Discontinued Active ingredient PENICILLIN V POTASSIUM Form and strength TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview V-CILLIN K is listed in Drugs@FDA under application 060003 (ANDA). Marketing status: Discontinued Active ingredient PENICILLIN V POTASSIUM Form and strength TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.